Furthermore, TM4SF1 has been well-documented for its ability to initiate carcinogenesis in hepatocellular carcinoma, ovarian cancer, pancreatic cancer, and other malignancies [38–40]. This evidence concerns the gene TM4SF1 and ovarian carcinoma.